- SCHE, which tracks an emerging markets index, has come under a lot of pressure over the last few months.
- Covid-19 variants are hammering countries that have been slow to vaccinate their populations. Further, Chinese regulators are cracking down on the business community. These factors are both hurting stocks.
- Yet, there is opportunity here. International stocks as a whole are attractively priced against U.S. stocks, so there is some relative value.
- Emerging markets are still expected to log strong growth over the next few years, so this is a longer term opportunity.
For further details see:
SCHE: Looking At Weakness Opportunistically